BridgeBio Pharma is seeking a Skeletal Dysplasia Account Manager who will drive the launch of Infigratinib, a first-in-class therapy for achondroplasia. This role is focused on building relationships with genetics and pediatrics specialists and exceeding sales goals while ensuring compliance with regulations.
A successful candidate will have significant experience in pharmaceuticals and must be willing to travel extensively, along with proven skills in relationship management and strategic planning. The position offers a competitive salary range of $155,000 - $210,000 and generous benefits.
#J-18808-LjbffrWest Region Skeletal Dysplasia Account Lead (Remote) in Remote at Unknown Company
This position is listed as full time and onsite.